WEDNESDAY, Oct. 29, 2025 An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. T
With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
The planned trial targets adults with Stage 2-4 chronic kidney disease and will track kidney function and inflammation markers. Recruitment starts after listing. Post Views: 1